The global Viral Vector Manufacturing market was valued at US$ 487.9 million in 2023 and is anticipated to reach US$ 678.8 million by 2030, witnessing a CAGR of 4.9% during the forecast period 2024-2030.

Viral Vector Manufacturing Market

Viral vectors represent one of the primary tools, which can be used to deliver the genetic material into cells.

Viral vectors can be utilized in gene therapy for the treatment of different diseases, such as heart defects, metabolic diseases, cancer, and neurodegenerative disorders. Viral vectors based on adenoviruses, adeno-associated viruses, lentiviruses, retroviruses, herpes simplex viruses, baculovirus, etc. are being routinely used in life sciences research and are finding applications in vaccinology and novel drug delivery approaches.

This report aims to provide a comprehensive presentation of the global market for Viral Vector Manufacturing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Viral Vector Manufacturing.

Report Scope

The Viral Vector Manufacturing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Viral Vector Manufacturing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Viral Vector Manufacturing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Viral Vector Manufacturing Market Report

Report Metric	Details
Report Name	Viral Vector Manufacturing Market
Accounted market size in 2023	US$ 487.9 million
Forecasted market size in 2030	US$ 678.8 million
CAGR	4.9%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Adenoviral Vectors Adeno-associated Viral Vectors Retroviral Vectors Lentiviral Vectors Other
Segment by Application	Gene Therapy Vaccinology
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	BioReliance, Cobra Biologics, Oxford BioMedica, UniQure, FinVector, MolMed, MassBiologics, FUJIFILM Diosynth Biotechnologies, Lonza, Biovian, Thermo Fisher Scientific (Brammer Bio)
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Viral Vector Manufacturing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Viral Vector Manufacturing Market growing?

Ans: The Viral Vector Manufacturing Market witnessing a CAGR of 4.9% during the forecast period 2024-2030.

What is the Viral Vector Manufacturing Market size in 2030?

Ans: The Viral Vector Manufacturing Market size in 2030 will be US$ 678.8 million.

Who are the main players in the Viral Vector Manufacturing Market report?

Ans: The main players in the Viral Vector Manufacturing Market are BioReliance, Cobra Biologics, Oxford BioMedica, UniQure, FinVector, MolMed, MassBiologics, FUJIFILM Diosynth Biotechnologies, Lonza, Biovian, Thermo Fisher Scientific (Brammer Bio)

What are the Application segmentation covered in the Viral Vector Manufacturing Market report?

Ans: The Applications covered in the Viral Vector Manufacturing Market report are Gene Therapy, Vaccinology

What are the Type segmentation covered in the Viral Vector Manufacturing Market report?

Ans: The Types covered in the Viral Vector Manufacturing Market report are Adenoviral Vectors, Adeno-associated Viral Vectors, Retroviral Vectors, Lentiviral Vectors, Other

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Viral Vector Manufacturing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Adenoviral Vectors

1.2.3 Adeno-associated Viral Vectors

1.2.4 Retroviral Vectors

1.2.5 Lentiviral Vectors

1.2.6 Other

1.3 Market by Application

1.3.1 Global Viral Vector Manufacturing Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Gene Therapy

1.3.3 Vaccinology

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Viral Vector Manufacturing Market Perspective (2019-2030)

2.2 Viral Vector Manufacturing Growth Trends by Region

2.2.1 Global Viral Vector Manufacturing Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Viral Vector Manufacturing Historic Market Size by Region (2019-2024)

2.2.3 Viral Vector Manufacturing Forecasted Market Size by Region (2025-2030)

2.3 Viral Vector Manufacturing Market Dynamics

2.3.1 Viral Vector Manufacturing Industry Trends

2.3.2 Viral Vector Manufacturing Market Drivers

2.3.3 Viral Vector Manufacturing Market Challenges

2.3.4 Viral Vector Manufacturing Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Viral Vector Manufacturing Players by Revenue

3.1.1 Global Top Viral Vector Manufacturing Players by Revenue (2019-2024)

3.1.2 Global Viral Vector Manufacturing Revenue Market Share by Players (2019-2024)

3.2 Global Viral Vector Manufacturing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Viral Vector Manufacturing Revenue

3.4 Global Viral Vector Manufacturing Market Concentration Ratio

3.4.1 Global Viral Vector Manufacturing Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Viral Vector Manufacturing Revenue in 2023

3.5 Viral Vector Manufacturing Key Players Head office and Area Served

3.6 Key Players Viral Vector Manufacturing Product Solution and Service

3.7 Date of Enter into Viral Vector Manufacturing Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Viral Vector Manufacturing Breakdown Data by Type

4.1 Global Viral Vector Manufacturing Historic Market Size by Type (2019-2024)

4.2 Global Viral Vector Manufacturing Forecasted Market Size by Type (2025-2030)

5 Viral Vector Manufacturing Breakdown Data by Application

5.1 Global Viral Vector Manufacturing Historic Market Size by Application (2019-2024)

5.2 Global Viral Vector Manufacturing Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Viral Vector Manufacturing Market Size (2019-2030)

6.2 North America Viral Vector Manufacturing Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Viral Vector Manufacturing Market Size by Country (2019-2024)

6.4 North America Viral Vector Manufacturing Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Viral Vector Manufacturing Market Size (2019-2030)

7.2 Europe Viral Vector Manufacturing Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Viral Vector Manufacturing Market Size by Country (2019-2024)

7.4 Europe Viral Vector Manufacturing Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Viral Vector Manufacturing Market Size (2019-2030)

8.2 Asia-Pacific Viral Vector Manufacturing Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Viral Vector Manufacturing Market Size by Region (2019-2024)

8.4 Asia-Pacific Viral Vector Manufacturing Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Viral Vector Manufacturing Market Size (2019-2030)

9.2 Latin America Viral Vector Manufacturing Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Viral Vector Manufacturing Market Size by Country (2019-2024)

9.4 Latin America Viral Vector Manufacturing Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Viral Vector Manufacturing Market Size (2019-2030)

10.2 Middle East & Africa Viral Vector Manufacturing Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Viral Vector Manufacturing Market Size by Country (2019-2024)

10.4 Middle East & Africa Viral Vector Manufacturing Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 BioReliance

11.1.1 BioReliance Company Detail

11.1.2 BioReliance Business Overview

11.1.3 BioReliance Viral Vector Manufacturing Introduction

11.1.4 BioReliance Revenue in Viral Vector Manufacturing Business (2019-2024)

11.1.5 BioReliance Recent Development

11.2 Cobra Biologics

11.2.1 Cobra Biologics Company Detail

11.2.2 Cobra Biologics Business Overview

11.2.3 Cobra Biologics Viral Vector Manufacturing Introduction

11.2.4 Cobra Biologics Revenue in Viral Vector Manufacturing Business (2019-2024)

11.2.5 Cobra Biologics Recent Development

11.3 Oxford BioMedica

11.3.1 Oxford BioMedica Company Detail

11.3.2 Oxford BioMedica Business Overview

11.3.3 Oxford BioMedica Viral Vector Manufacturing Introduction

11.3.4 Oxford BioMedica Revenue in Viral Vector Manufacturing Business (2019-2024)

11.3.5 Oxford BioMedica Recent Development

11.4 UniQure

11.4.1 UniQure Company Detail

11.4.2 UniQure Business Overview

11.4.3 UniQure Viral Vector Manufacturing Introduction

11.4.4 UniQure Revenue in Viral Vector Manufacturing Business (2019-2024)

11.4.5 UniQure Recent Development

11.5 FinVector

11.5.1 FinVector Company Detail

11.5.2 FinVector Business Overview

11.5.3 FinVector Viral Vector Manufacturing Introduction

11.5.4 FinVector Revenue in Viral Vector Manufacturing Business (2019-2024)

11.5.5 FinVector Recent Development

11.6 MolMed

11.6.1 MolMed Company Detail

11.6.2 MolMed Business Overview

11.6.3 MolMed Viral Vector Manufacturing Introduction

11.6.4 MolMed Revenue in Viral Vector Manufacturing Business (2019-2024)

11.6.5 MolMed Recent Development

11.7 MassBiologics

11.7.1 MassBiologics Company Detail

11.7.2 MassBiologics Business Overview

11.7.3 MassBiologics Viral Vector Manufacturing Introduction

11.7.4 MassBiologics Revenue in Viral Vector Manufacturing Business (2019-2024)

11.7.5 MassBiologics Recent Development

11.8 FUJIFILM Diosynth Biotechnologies

11.8.1 FUJIFILM Diosynth Biotechnologies Company Detail

11.8.2 FUJIFILM Diosynth Biotechnologies Business Overview

11.8.3 FUJIFILM Diosynth Biotechnologies Viral Vector Manufacturing Introduction

11.8.4 FUJIFILM Diosynth Biotechnologies Revenue in Viral Vector Manufacturing Business (2019-2024)

11.8.5 FUJIFILM Diosynth Biotechnologies Recent Development

11.9 Lonza

11.9.1 Lonza Company Detail

11.9.2 Lonza Business Overview

11.9.3 Lonza Viral Vector Manufacturing Introduction

11.9.4 Lonza Revenue in Viral Vector Manufacturing Business (2019-2024)

11.9.5 Lonza Recent Development

11.10 Biovian

11.10.1 Biovian Company Detail

11.10.2 Biovian Business Overview

11.10.3 Biovian Viral Vector Manufacturing Introduction

11.10.4 Biovian Revenue in Viral Vector Manufacturing Business (2019-2024)

11.10.5 Biovian Recent Development

11.11 Thermo Fisher Scientific (Brammer Bio)

11.11.1 Thermo Fisher Scientific (Brammer Bio) Company Detail

11.11.2 Thermo Fisher Scientific (Brammer Bio) Business Overview

11.11.3 Thermo Fisher Scientific (Brammer Bio) Viral Vector Manufacturing Introduction

11.11.4 Thermo Fisher Scientific (Brammer Bio) Revenue in Viral Vector Manufacturing Business (2019-2024)

11.11.5 Thermo Fisher Scientific (Brammer Bio) Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

FUJIFILM Diosynth Biotechnologies

Lonza

Biovian

Thermo Fisher Scientific (Brammer Bio)

List of Tables

Table 1. Global Viral Vector Manufacturing Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Adenoviral Vectors

Table 3. Key Players of Adeno-associated Viral Vectors

Table 4. Key Players of Retroviral Vectors

Table 5. Key Players of Lentiviral Vectors

Table 6. Key Players of Other

Table 7. Global Viral Vector Manufacturing Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Viral Vector Manufacturing Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 9. Global Viral Vector Manufacturing Market Size by Region (2019-2024) & (US$ Million)

Table 10. Global Viral Vector Manufacturing Market Share by Region (2019-2024)

Table 11. Global Viral Vector Manufacturing Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 12. Global Viral Vector Manufacturing Market Share by Region (2025-2030)

Table 13. Viral Vector Manufacturing Market Trends

Table 14. Viral Vector Manufacturing Market Drivers

Table 15. Viral Vector Manufacturing Market Challenges

Table 16. Viral Vector Manufacturing Market Restraints

Table 17. Global Viral Vector Manufacturing Revenue by Players (2019-2024) & (US$ Million)

Table 18. Global Viral Vector Manufacturing Market Share by Players (2019-2024)

Table 19. Global Top Viral Vector Manufacturing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Vector Manufacturing as of 2023)

Table 20. Ranking of Global Top Viral Vector Manufacturing Companies by Revenue (US$ Million) in 2023

Table 21. Global 5 Largest Players Market Share by Viral Vector Manufacturing Revenue (CR5 and HHI) & (2019-2024)

Table 22. Key Players Headquarters and Area Served

Table 23. Key Players Viral Vector Manufacturing Product Solution and Service

Table 24. Date of Enter into Viral Vector Manufacturing Market

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Viral Vector Manufacturing Market Size by Type (2019-2024) & (US$ Million)

Table 27. Global Viral Vector Manufacturing Revenue Market Share by Type (2019-2024)

Table 28. Global Viral Vector Manufacturing Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 29. Global Viral Vector Manufacturing Revenue Market Share by Type (2025-2030)

Table 30. Global Viral Vector Manufacturing Market Size by Application (2019-2024) & (US$ Million)

Table 31. Global Viral Vector Manufacturing Revenue Market Share by Application (2019-2024)

Table 32. Global Viral Vector Manufacturing Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 33. Global Viral Vector Manufacturing Revenue Market Share by Application (2025-2030)

Table 34. North America Viral Vector Manufacturing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. North America Viral Vector Manufacturing Market Size by Country (2019-2024) & (US$ Million)

Table 36. North America Viral Vector Manufacturing Market Size by Country (2025-2030) & (US$ Million)

Table 37. Europe Viral Vector Manufacturing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 38. Europe Viral Vector Manufacturing Market Size by Country (2019-2024) & (US$ Million)

Table 39. Europe Viral Vector Manufacturing Market Size by Country (2025-2030) & (US$ Million)

Table 40. Asia-Pacific Viral Vector Manufacturing Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 41. Asia-Pacific Viral Vector Manufacturing Market Size by Region (2019-2024) & (US$ Million)

Table 42. Asia-Pacific Viral Vector Manufacturing Market Size by Region (2025-2030) & (US$ Million)

Table 43. Latin America Viral Vector Manufacturing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Latin America Viral Vector Manufacturing Market Size by Country (2019-2024) & (US$ Million)

Table 45. Latin America Viral Vector Manufacturing Market Size by Country (2025-2030) & (US$ Million)

Table 46. Middle East & Africa Viral Vector Manufacturing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 47. Middle East & Africa Viral Vector Manufacturing Market Size by Country (2019-2024) & (US$ Million)

Table 48. Middle East & Africa Viral Vector Manufacturing Market Size by Country (2025-2030) & (US$ Million)

Table 49. BioReliance Company Detail

Table 50. BioReliance Business Overview

Table 51. BioReliance Viral Vector Manufacturing Product

Table 52. BioReliance Revenue in Viral Vector Manufacturing Business (2019-2024) & (US$ Million)

Table 53. BioReliance Recent Development

Table 54. Cobra Biologics Company Detail

Table 55. Cobra Biologics Business Overview

Table 56. Cobra Biologics Viral Vector Manufacturing Product

Table 57. Cobra Biologics Revenue in Viral Vector Manufacturing Business (2019-2024) & (US$ Million)

Table 58. Cobra Biologics Recent Development

Table 59. Oxford BioMedica Company Detail

Table 60. Oxford BioMedica Business Overview

Table 61. Oxford BioMedica Viral Vector Manufacturing Product

Table 62. Oxford BioMedica Revenue in Viral Vector Manufacturing Business (2019-2024) & (US$ Million)

Table 63. Oxford BioMedica Recent Development

Table 64. UniQure Company Detail

Table 65. UniQure Business Overview

Table 66. UniQure Viral Vector Manufacturing Product

Table 67. UniQure Revenue in Viral Vector Manufacturing Business (2019-2024) & (US$ Million)

Table 68. UniQure Recent Development

Table 69. FinVector Company Detail

Table 70. FinVector Business Overview

Table 71. FinVector Viral Vector Manufacturing Product

Table 72. FinVector Revenue in Viral Vector Manufacturing Business (2019-2024) & (US$ Million)

Table 73. FinVector Recent Development

Table 74. MolMed Company Detail

Table 75. MolMed Business Overview

Table 76. MolMed Viral Vector Manufacturing Product

Table 77. MolMed Revenue in Viral Vector Manufacturing Business (2019-2024) & (US$ Million)

Table 78. MolMed Recent Development

Table 79. MassBiologics Company Detail

Table 80. MassBiologics Business Overview

Table 81. MassBiologics Viral Vector Manufacturing Product

Table 82. MassBiologics Revenue in Viral Vector Manufacturing Business (2019-2024) & (US$ Million)

Table 83. MassBiologics Recent Development

Table 84. FUJIFILM Diosynth Biotechnologies Company Detail

Table 85. FUJIFILM Diosynth Biotechnologies Business Overview

Table 86. FUJIFILM Diosynth Biotechnologies Viral Vector Manufacturing Product

Table 87. FUJIFILM Diosynth Biotechnologies Revenue in Viral Vector Manufacturing Business (2019-2024) & (US$ Million)

Table 88. FUJIFILM Diosynth Biotechnologies Recent Development

Table 89. Lonza Company Detail

Table 90. Lonza Business Overview

Table 91. Lonza Viral Vector Manufacturing Product

Table 92. Lonza Revenue in Viral Vector Manufacturing Business (2019-2024) & (US$ Million)

Table 93. Lonza Recent Development

Table 94. Biovian Company Detail

Table 95. Biovian Business Overview

Table 96. Biovian Viral Vector Manufacturing Product

Table 97. Biovian Revenue in Viral Vector Manufacturing Business (2019-2024) & (US$ Million)

Table 98. Biovian Recent Development

Table 99. Thermo Fisher Scientific (Brammer Bio) Company Detail

Table 100. Thermo Fisher Scientific (Brammer Bio) Business Overview

Table 101. Thermo Fisher Scientific (Brammer Bio) Viral Vector Manufacturing Product

Table 102. Thermo Fisher Scientific (Brammer Bio) Revenue in Viral Vector Manufacturing Business (2019-2024) & (US$ Million)

Table 103. Thermo Fisher Scientific (Brammer Bio) Recent Development

Table 104. Research Programs/Design for This Report

Table 105. Key Data Information from Secondary Sources

Table 106. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Viral Vector Manufacturing Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Viral Vector Manufacturing Market Share by Type: 2023 VS 2030

Figure 3. Adenoviral Vectors Features

Figure 4. Adeno-associated Viral Vectors Features

Figure 5. Retroviral Vectors Features

Figure 6. Lentiviral Vectors Features

Figure 7. Other Features

Figure 8. Global Viral Vector Manufacturing Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 9. Global Viral Vector Manufacturing Market Share by Application: 2023 VS 2030

Figure 10. Gene Therapy Case Studies

Figure 11. Vaccinology Case Studies

Figure 12. Viral Vector Manufacturing Report Years Considered

Figure 13. Global Viral Vector Manufacturing Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 14. Global Viral Vector Manufacturing Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global Viral Vector Manufacturing Market Share by Region: 2023 VS 2030

Figure 16. Global Viral Vector Manufacturing Market Share by Players in 2023

Figure 17. Global Top Viral Vector Manufacturing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Vector Manufacturing as of 2023)

Figure 18. The Top 10 and 5 Players Market Share by Viral Vector Manufacturing Revenue in 2023

Figure 19. North America Viral Vector Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. North America Viral Vector Manufacturing Market Share by Country (2019-2030)

Figure 21. United States Viral Vector Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Canada Viral Vector Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Viral Vector Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Viral Vector Manufacturing Market Share by Country (2019-2030)

Figure 25. Germany Viral Vector Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. France Viral Vector Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. U.K. Viral Vector Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Italy Viral Vector Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Russia Viral Vector Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Nordic Countries Viral Vector Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Asia-Pacific Viral Vector Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Asia-Pacific Viral Vector Manufacturing Market Share by Region (2019-2030)

Figure 33. China Viral Vector Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Japan Viral Vector Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. South Korea Viral Vector Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Southeast Asia Viral Vector Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. India Viral Vector Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Australia Viral Vector Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Latin America Viral Vector Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Latin America Viral Vector Manufacturing Market Share by Country (2019-2030)

Figure 41. Mexico Viral Vector Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Brazil Viral Vector Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Middle East & Africa Viral Vector Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Middle East & Africa Viral Vector Manufacturing Market Share by Country (2019-2030)

Figure 45. Turkey Viral Vector Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Saudi Arabia Viral Vector Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. BioReliance Revenue Growth Rate in Viral Vector Manufacturing Business (2019-2024)

Figure 48. Cobra Biologics Revenue Growth Rate in Viral Vector Manufacturing Business (2019-2024)

Figure 49. Oxford BioMedica Revenue Growth Rate in Viral Vector Manufacturing Business (2019-2024)

Figure 50. UniQure Revenue Growth Rate in Viral Vector Manufacturing Business (2019-2024)

Figure 51. FinVector Revenue Growth Rate in Viral Vector Manufacturing Business (2019-2024)

Figure 52. MolMed Revenue Growth Rate in Viral Vector Manufacturing Business (2019-2024)

Figure 53. MassBiologics Revenue Growth Rate in Viral Vector Manufacturing Business (2019-2024)

Figure 54. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in Viral Vector Manufacturing Business (2019-2024)

Figure 55. Lonza Revenue Growth Rate in Viral Vector Manufacturing Business (2019-2024)

Figure 56. Biovian Revenue Growth Rate in Viral Vector Manufacturing Business (2019-2024)

Figure 57. Thermo Fisher Scientific (Brammer Bio) Revenue Growth Rate in Viral Vector Manufacturing Business (2019-2024)

Figure 58. Bottom-up and Top-down Approaches for This Report

Figure 59. Data Triangulation

Figure 60. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions